Atombeat Inc.

Atombeat Inc. was founded by a team of elite computational and medicinal chemists with a mission to make advanced computational drug discovery accessible to all. We offer a range of powerful tools and services, from Free Energy Perturbation (FEP) software to computer-aided cyclic peptide discovery, enabling researchers to tackle complex targets and explore emerging therapeutic modalities—without requiring extensive computational expertise or resources. At Atombeat, our primary focus is to develop and deliver cutting-edge, physics-based and AI-powered computational tools for hit discovery and lead optimization. With deep expertise in forcefield and FEP algorithm development, as well as cloud infrastructure optimization for faster simulations, we empower researchers to accelerate their drug discovery efforts. Supported by our experienced team of medicinal chemists, we leverage the full power of our tools to directly contribute to the success of our customers' drug discovery pipelines. We offer flexible collaboration options—from SaaS software engagement to fee-for-service hit discovery and CADD FTE—dedicated to helping our customers succeed with our expertise and innovative solutions.